‘Really exciting times’: One biotech’s view of radiopharma’s boom

‘Really exciting times’: One biotech’s view of radiopharma’s boom

As far as cancer treatments go, radiopharmaceuticals are conceptually simple. After all, radioactive isotopes are very good at killing cancer cells. And as targeting technology improves, large pharma companies are paying closer attention to the drug field and the many smaller biotechnology firms within it.
This radio-renaissance belies the long history of radiation-based drugs, the idea for which has been around for more than half a…
Read More…

Source: https://www.biopharmadive.com/news/radiopharmaceuticals-cancer-ratio-therapeutics/727241/